Clinical Trial Update: Apolipoprotein CIII Reduction Via Colchicine [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial completed evaluating colchicine as a strategy to reduce apolipoprotein CIII in hypertriglyceridemia. The study also relates to gout and per…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hypertriglyceridemia
• Pericarditis

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Scripps Translational Science Institute | Conditions: Hypertriglyceridemia, Gout | EARLY_Phase 1 | Status: COMPLETED